COURT-RULING ·Filed Aug 12, 2026

SNY

Sanofi
NEUTRAL
Impact 2/10
Horizonmonths Processed1mo ago CourtView Ruling on CourtListener
Court ruling (district)
Actionable Insight • Neutral

This is a minor procedural loss in a long-running antitrust case. No material financial impact — monitor for future rulings on class certification or summary judgment that would affect settlement leverage.

DirectionNeutral
Confidencehigh
Horizonmonths
Latest settled — T+20d
SNY ▼ -2.26% at T+20d
NEUTRAL call ✗ call lost -2.26% · α vs SPY -0.37% · entry $43.71 → $42.72
Next anchor: T+60d in 5w
Latest observation: T+33 -2.79% FF3 residual α
Entry anchored
Aug 11, 04:39 PM ET
via 1-min bar
T+1d
+0.16%
call +0.16% · α -0.54%
$43.78
settled 7w ago
T+5d
+4.85%
call +4.85% · α +5.29%
$45.83
settled 6w ago
T+20d
-2.26%
call -2.26% · α -0.37%
$42.72
settled 23d ago
T+60d
—
call — · α —
—
in 5w

Price Chart

Loading chart...

Executive Summary

Sanofi lost a discovery dispute in a pending antitrust class action over alleged coordinated retraction of hospital discounts. The court denied Sanofi's request for a protective order requiring 10 days' notice before plaintiffs contact former employees, and ordered Sanofi to provide contact information for former employees within 10 business days. This is a routine procedural ruling on discovery management with no material financial exposure — it does not address the merits of the antitrust claims.

Court Ruling Details

Ruling Date
Aug 12, 2026
Court
United States District Court for the Western District of New York
Court Level
District
Judge
Colleen D. Holland
Case Type
antitrust
Ruling Type
discovery
Outcome
LOSS — ruling against this company
Will It Be Appealed?
Unlikely
Precedent Risk
LOW

Key Facts

  • Sanofi is a defendant in a putative antitrust class action alleging coordinated retraction of discounts for safety-net hospitals.
  • The court denied Sanofi's request for a protective order requiring 10 days' notice before plaintiffs contact former employees.
  • Sanofi was ordered to provide contact information for former employees within the scope of Rule 26(a)(1) within 10 business days.
  • The ruling is procedural — it does not address the merits of the antitrust claims.

Financial Impact

No damages awarded or financial exposure quantified in the ruling.

Risk Factors

  • The underlying antitrust class action remains pending and could result in material liability if plaintiffs prevail on the merits.
  • The ruling allows plaintiffs broader access to former employees for discovery, potentially strengthening their case.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
57% bullish (30 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 court opinion from CourtListener.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-faa5711d54-SNY
9 reports for SNY
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+20▲ +4.04%Jul 31, 2026
Filters
Rows
Reports for SNY — sortable, filterable
TypeNow
Aug 31, 2026
4w ago
Court Ruling
NEUTRAL ★ 2/10
$44.36 $40.74▼ −8.16%▼ −7.97%$39.92 (−10.01%)
Aug 17, 2026
6w ago
Court Ruling
BULLISH ★ 4/10
$44.41 $42.40▼ −4.53%▼ −2.55%$39.92 (−10.11%)
Aug 12, 2026
7w ago
Court Ruling
NEUTRAL ★ 2/10
$43.71 $42.72▼ −2.26%▼ −0.37%$39.92 (−8.67%)
Jul 31, 2026
9w ago
Court Ruling
BULLISH ★ 5/10
$43.08 $44.82▲ +4.04%▲ +1.05%$39.92 (−7.34%)
Jul 30, 2026
9w ago
6-K
MIXED ★ 6/10
$42.89 $44.84▲ +4.55%▲ +0.58%$39.92 (−6.92%)
Jul 27, 2026
9w ago
6-K
BEARISH ★ 5/10
$44.00 $45.69▼ −3.84%▼ −0.54%$39.92 (+9.27%)
Jul 17, 2026
11w ago
6-K
BULLISH ★ 6/10
$44.66 $43.72▼ −2.10%▼ −6.55%$39.92 (−10.61%)
Jul 7, 2026
12w ago
6-K
BULLISH ★ 5/10
$42.98 $42.95▼ −0.07%▼ −1.40%$39.92 (−7.12%)
Apr 13, 2026
24w ago
Court Ruling
NEUTRAL ★ 3/10
$44.49 $42.50▼ −4.48%▼ −12.20%$39.92 (−10.28%)
Showing 9 of 9

US Market Status

Market Closed — Opens Mon (65h 4m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access